ChemicalBook--->CAS DataBase List--->4891-15-0

4891-15-0

4891-15-0 Structure

4891-15-0 Structure
IdentificationBack Directory
[Name]

estra-1,3,5(10)-triene-3,17beta-diol 3-[bis(2-chloroethyl)carbamate] 17-(dihydrogen phosphate)
[CAS]

4891-15-0
[Synonyms]

LS 299
Proesta
Leo 299
estramustine phosphate
ESTRADIOLMUSTARDPHOSPHATE
Estradiol 3-N-bis(2-chloroethyl)carbamate-17β-phosphate
Estradiol 3-[bis(2-chloroethyl)carbamate] dihydrogen phosphate
Estradiol, 3-[bis(2-chloroethyl)carbamate] dihydrogen phosphate (8CI)
Estradiol, 3-[bis(2-chloroethyl)carbamate], 17-(dihydrogen phosphate) (7CI)
estra-1,3,5(10)-triene-3,17β-diol 3-[bis(2-chloroethyl)carbaMate] 17-(dihydrogen phosphate)
Carbamic acid, bis(2-chloroethyl)-, 3-ester with estradiol dihydrogen phosphate (ester) (8CI)
estra-1,3,5(10)-triene-3,17beta-diol 3-[bis(2-chloroethyl)carbamate] 17-(dihydrogen phosphate)
Estra-1,3,5(10)-triene-3,17-diol (17β)-, 3-[bis(2-chloroethyl)carbamate] 17-(dihydrogen phosphate)
(17beta)-Estra-1,3,5(10)-triene-3,17-diol 3-[bis(2-chloroethyl)carbamate] 17-(dihydrogen phosphate)
Estra-1,3,5(10)-triene-3,17-diol (17β)-, 3-[N,N-bis(2-chloroethyl)carbamate], 17-(dihydrogen phosphate)
estra-1,3,5(10)-triene-3,17beta-diol 3-[bis(2-chloroethyl)carbamate] 17-(dihydrogen phosphate) USP/EP/BP
[EINECS(EC#)]

225-512-3
[Molecular Formula]

C23H32Cl2NO6P
[MDL Number]

MFCD00869450
[MOL File]

4891-15-0.mol
[Molecular Weight]

520.383
Safety DataBack Directory
[Symbol(GHS) ]

Health Hazard (GHS08)
GHS08
[Signal word ]

Danger
[Hazard statements ]

H360-H351
[Precautionary statements ]

P201-P202-P281-P308+P313-P405-P501
Hazard InformationBack Directory
[Originator]

Estracyt,Bastian Werk,W. Germany,1973
[Definition]

ChEBI: A steroid phosphate which is the 17-O-phospho derivative of estramustine.
[Manufacturing Process]

A solution in dry benzene of 82 grams of bis(β-chloroethyl)amine freshly liberated from its hydrochloride is added gradually to a solution of 36 grams of carbonyl chloride (phosgene) in benzene at a temperature below 10°C. The mixture is mechanically stirred for 3 hours, the precipitate of bis(β- chloroethyl)amine hydrochloride is removed by filtration and the benzene is distilled off on a water bath. The residue is distilled in vacuo and the Nchloroformyl-bis(β-chloroethyl)amine is obtained as a pale yellow oil with a BP of 114° to 116°C at 1 mm Hg.
To a solution of 16.35 grams of estradiol in 75 ml of dry pyridine, 21.00 grams of the abovementioned chloroformyl-bis(β-chloroethyl)amine are added while stirring and cooling with ice-water.
The reaction mixture is allowed to stand at room temperature for 60 to 70 hours under the exclusion of air humidity. Then the excess of the chloroformyl compound is hydrolyzed with crushed ice. Ethyl acetate is added and after shaking, the ethyl acetate solution is separated and washed with water, dried over sodium sulfate and evaporated in vacuo to dryness.
The residue is the 3-N-bis(beta-chloroethyl)carbamate of estradiol. The compound melts at 101° to 103°C after recrystallization from isopropyl ether plus hexane (1:1).
To a solution of 2.3 ml of phosphorus oxychloride in 50 ml of dry pyridine is added a solution of 2.2 grams of 3-N-bis(β-chloroethyl)carbamate of estradiol while stirring and at a temperature of about -10°C. The reaction mixture is allowed to stand at about 0°C for 1? hours, whereupon it is hydrolyzed by pouring it into ice-water. The main part of the pyridine is evaporated in vacuo, whereupon the residue is poured into 100 ml of cold 3.5 N hydrochloric acid with stirring. The precipitate thus obtained is isolated and washed with 0.1 N hydrochloric acid and water.
The compound, which consists of the 17-phosphate of estradiol-3-N-bis(β- chloroethyl)carbamate, melts under decomposition at about 155°C. It is soluble in an aqueous solution of alkali.
[Therapeutic Function]

Cancer chemotherapy
[Clinical Use]

Alkylating agent:
Prostate cancer
[Drug interactions]

Potentially hazardous interactions with other drugs
Antipsychotics: avoid concomitant use with clozapine (increased risk of agranulocytosis).
Bisphosphonates: concentration increased by sodium clodronate
[Metabolism]

Estramustine sodium phosphate is absorbed from the gastrointestinal tract and rapidly dephosphorylated in the intestine and prostate to estramustine and its oxidised isomer estromustine. Some hydrolysis of the carbamate linkage occurs in the liver, releasing estradiol, estrone, and the normustine group. Estramustine and estromustine are excreted with their metabolites mainly in the faeces.
4891-15-0 suppliers list
Company Name: Capot Chemical Co.,Ltd.  
Telephone: +86-(0)57185586718 +86-13336195806
Website: www.capot.com/
Company Name: Dideu Industries Group Limited  
Telephone: +8617392712697
Website: www.dideu.com
Company Name: AFINE CHEMICALS LIMITED  
Telephone: +86-571-85134551 +86-18958018566
Website: www.afinechem.com/index.html
Company Name: CONIER CHEM AND PHARMA LIMITED  
Telephone:
Website: http://www.conier.com/
Company Name: Zhengzhou Akem Chemical Co., Ltd  
Telephone: 13303867194
Website: www.acmechem.cn/
Company Name: Shaanxi DIDU pharmaceutical and Chemical Co., Ltd  
Telephone: 029-029-029-81148696 18161915376
Website: http://www.dideu.cn
Company Name: TargetMol Chemicals Inc.  
Telephone: 4008200310 15002144251
Website: https://www.targetmol.cn/
Company Name: Shandong Ziyi Pharmaceutical Co., Ltd.  
Telephone: 13173053288
Website:
Tags:4891-15-0 Related Product Information
15091-98-2 2998-57-4 52205-73-9 2114-18-3